Topiramate Tablet, Film Coated
Product Images NDC 68788-7568

4 FDA label images from Preferred Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68788-7568). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 01

7ea951b6 B020 481f 8acc 12fb7a3a69fd 01
Chemical structure of the active ingredient topiramate, showing its molecular arrangement with functional groups and stereochemistry.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 02

7ea951b6 B020 481f 8acc 12fb7a3a69fd 02
A Kaplan-Meier plot showing cumulative rates for time to first seizure over days up to 500. It compares two topiramate dosage groups: 50 mg/day (solid line, N=234) and 400 mg/day (dashed line, N=236), illustrating lower cumulative seizure rates over time with the higher dose. A p-value of 0.0002 is noted.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 03

7ea951b6 B020 481f 8acc 12fb7a3a69fd 03
Bar chart showing change from baseline to double-blind phase in average monthly migraine period rate with standard error bars. The chart compares placebo to topiramate dosages of 50 mg/day, 100 mg/day, and 200 mg/day across two studies (Study 11 and Study 12). Higher doses of topiramate correspond with greater reductions in migraine period rates, with statistical significance indicated for 100 mg/day and 200 mg/day groups.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 07

7ea951b6 B020 481f 8acc 12fb7a3a69fd 07
Label for Topiramate Tablets USP 200 mg film-coated tablets, generic for Topamax, produced by Preferred Pharmaceuticals, Inc. The label includes dosage information in English and Spanish, storage instructions at 20° to 25°C, a caution about federal law restricting drug transfer, and manufacturing details for Zydus Pharmaceuticals USA Inc. It features a barcode, a QR code, and space for batch and lot numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.